Completed PHASE3 INTERVENTIONAL 2-arm NCT01453881

Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation (EFFECT-EV)

Randomized Clinical Trials to Compare Asthma Control Efficacy of the Fine-particle Combination Formoterol/Beclomethasone by pMDI Administered With and Without Spacer.

Sponsor: Universidade Federal de Pernambuco

Conditions Asthma

Interventions Comparator Spacer

Updated 5 times since 2017 Last updated: Mar 29, 2015 Started: Apr 30, 2011 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Asthma and is currently completed. Universidade Federal de Pernambuco leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Federal de Pernambuco
Universidade Federal do vale do São Francisco

Data source: Universidade Federal de Pernambuco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Recife, Brazil